Reminder: Ra Medical Systems to Host Webcast Discussing the Role of Excimer Lasers in the Treatment of Psoriasis during the P...
December 01 2020 - 6:50AM
Business Wire
Webcast to feature Theodore J. Daly, MD, FAAD,
FSPD, FASD, 37-year dermatology veteran with more than 20 years of
experience using excimer lasers
Ra Medical Systems, Inc. (NYSE: RMED) is hosting a webcast, The
Inimitable Role of Excimer Lasers During the COVID-19 Pandemic,
featuring Theodore J. Daly, MD, FAAD, FSPD, FASD, Director of
Garden City Dermatology, discussing the use of excimer lasers such
as the Pharos excimer laser system for the treatment of psoriasis
during the pandemic.
Presentation topics will include:
- Reviewing American Academy of Dermatology (AAD) guidance on the
use of immunosuppressive agents during COVID-19 pandemic
- Discussing the impact on day-to-day clinical practice and
individual patient treatment regimens
- Exploring alternative treatment modalities, including excimer
lasers
Date:
Wednesday, December 2, 2020
Time:
7:00-8:00 p.m. Eastern time
Pre-registration:
Here
If you are unable to attend the live event, an archived webcast
will be available on the Events section of the Ra Medical website
here.
Theodore J. Daly, MD, a triple board certified
dermatologist who has been in practice for 37 years, is a staff
member at the Mt. Sinai Icahn School of Medicine. He focuses on the
treatment of psoriasis and has used excimer lasers for more than 20
years. He has authored numerous publications and has been featured
on the Today Show and Fox and Friends, and in interviews on CNN and
MSNBC among others. He is in private practice at Garden City
Dermatology and The Garden Spa in Garden City, Long Island, NY.
About Ra Medical Systems
Ra Medical Systems commercializes excimer lasers and catheters
for the treatment of vascular and dermatological diseases. In May
2017 the DABRA excimer laser system received FDA 510(k) clearance
in the U.S. for crossing chronic total occlusions, or CTOs, in
patients with symptomatic infrainguinal lower extremity vascular
disease with an intended use for ablating a channel in occlusive
peripheral vascular disease. The Pharos excimer laser system is
FDA-cleared and is used as a tool in the treatment of psoriasis,
vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are
both based on Ra Medical’s core excimer laser technology platform
and deploy similar mechanisms of action. Ra Medical manufactures
DABRA and Pharos excimer lasers and catheters in a
32,000-square-foot facility located in Carlsbad, Calif. The
vertically integrated facility is ISO 13485 certified and is
licensed by the State of California to manufacture sterile,
single-use catheters in controlled environments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201201005148/en/
At the Company: Andrew Jackson Chief Financial Officer,
Ra Medical Systems 760-496-9540 ajackson@ramed.com
Investors: LHA Investor Relations Jody Cain 310-691-7100
jcain@lhai.com
Ra Medical Systems (NYSE:RMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ra Medical Systems (NYSE:RMED)
Historical Stock Chart
From Apr 2023 to Apr 2024